InsidersTradesSigma
HEM파마: management transactions · South Korea · DART (FSS)
DART:hemKR·DART (FSS)Mcap 426.2Bn€Healthcare
Browse the full insider trade history of HEM파마, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, HEM파마 has recorded 4 insider filings. Market capitalisation: €426.2bn. The latest transaction was disclosed on 6 April 2026 — Sale. Among the most active insiders: HEM파마. Every trade is accessible without an account.
4
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
2 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
60300.00 €
Analyst consensus
Income statement
Revenue12.98 Bn€
Gross profit631.5 M€5% margin
Net income−23.84 Bn€-183.7% margin
Balance sheet & cash
Market cap426.24 Bn€
Total debt19.26 Bn€
Free Cash Flow−18.33 Bn€
Debt / Equity369%
Profitability & ownership
ROE-151.4%
ROA-22.0%
% insiders25.7%
% institutions0.0%
Last declaration on 6 April 2026
Declarations4 total
Executives●Other0DART
DART:20260313000680·details not loaded
Executives●Other0DART
DART:20260311004552·details not loaded
4 of 4 declarations